MYDA Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,000
Closed -$450K 161
2024
Q3
$450K Buy
+10,000
New +$450K 0.1% 91